Click for best price
Molecular Diagnosis Therapy Market Size, Share 2022
Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.
This report contains market size and forecasts of Molecular Diagnosis and Therapy in Global, including the following market information:
Global Molecular Diagnosis and Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Molecular Diagnosis and Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Molecular Diagnosis and Therapy include Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biom?rieux Sa, Danaher Corporation, Diasorin, Grifols, Hologic and Illumina, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Molecular Diagnosis and Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnosis and Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Molecular Diagnosis and Therapy Market Segment Percentages, by Type, 2021 (%)
PCR
DNA Sequencing
NGS
Global Molecular Diagnosis and Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Molecular Diagnosis and Therapy Market Segment Percentages, by Application, 2021 (%)
Diagnostic Laboratories
Research & Academic Laboratories
Global Molecular Diagnosis and Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Molecular Diagnosis and Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Diagnosis and Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Molecular Diagnosis and Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Agilent Technologies
Becton, Dickinson and Company
Biom?rieux Sa
Danaher Corporation
Diasorin
Grifols
Hologic
Illumina
Qiagen
Roche Diagnostics
Siemens AG
Thermo Fisher Scientific
| Report Attributes |
Report Details |
| Report Title |
Molecular Diagnosis and Therapy Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnosis and Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnosis and Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnosis and Therapy Overall Market Size
2.1 Global Molecular Diagnosis and Therapy Market Size: 2021 VS 2028
2.2 Global Molecular Diagnosis and Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnosis and Therapy Players in Global Market
3.2 Top Global Molecular Diagnosis and Therapy Companies Ranked by Revenue
3.3 Global Molecular Diagnosis and Therapy Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnosis and Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Molecular Diagnosis and Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnosis and Therapy Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnosis and Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnosis and Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Molecular Diagnosis and Therapy Market Size Markets, 2021 & 2028
4.1.2 PCR
4.1.3 DNA Sequencing
4.1.4 NGS
4.2 By Type - Global Molecular Diagnosis and Therapy Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnosis and Therapy Revenue, 2017-2022
4.2.2 By Type - Global Molecular Diagnosis and Therapy Revenue, 2023-2028
4.2.3 By Type - Global Molecular Diagnosis and Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnosis and Therapy Market Size, 2021 & 2028
5.1.2 Diagnostic Laboratories
5.1.3 Research & Academic Laboratories
5.2 By Application - Global Molecular Diagnosis and Therapy Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnosis and Therapy Revenue, 2017-2022
5.2.2 By Application - Global Molecular Diagnosis and Therapy Revenue, 2023-2028
5.2.3 By Application - Global Molecular Diagnosis and Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Molecular Diagnosis and Therapy Market Size, 2021 & 2028
6.2 By Region - Global Molecular Diagnosis and Therapy Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnosis and Therapy Revenue, 2017-2022
6.2.2 By Region - Global Molecular Diagnosis and Therapy Revenue, 2023-2028
6.2.3 By Region - Global Molecular Diagnosis and Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Molecular Diagnosis and Therapy Revenue, 2017-2028
6.3.2 US Molecular Diagnosis and Therapy Market Size, 2017-2028
6.3.3 Canada Molecular Diagnosis and Therapy Market Size, 2017-2028
6.3.4 Mexico Molecular Diagnosis and Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnosis and Therapy Revenue, 2017-2028
6.4.2 Germany Molecular Diagnosis and Therapy Market Size, 2017-2028
6.4.3 France Molecular Diagnosis and Therapy Market Size, 2017-2028
6.4.4 U.K. Molecular Diagnosis and Therapy Market Size, 2017-2028
6.4.5 Italy Molecular Diagnosis and Therapy Market Size, 2017-2028
6.4.6 Russia Molecular Diagnosis and Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Molecular Diagnosis and Therapy Market Size, 2017-2028
6.4.8 Benelux Molecular Diagnosis and Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnosis and Therapy Revenue, 2017-2028
6.5.2 China Molecular Diagnosis and Therapy Market Size, 2017-2028
6.5.3 Japan Molecular Diagnosis and Therapy Market Size, 2017-2028
6.5.4 South Korea Molecular Diagnosis and Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Molecular Diagnosis and Therapy Market Size, 2017-2028
6.5.6 India Molecular Diagnosis and Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Molecular Diagnosis and Therapy Revenue, 2017-2028
6.6.2 Brazil Molecular Diagnosis and Therapy Market Size, 2017-2028
6.6.3 Argentina Molecular Diagnosis and Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnosis and Therapy Revenue, 2017-2028
6.7.2 Turkey Molecular Diagnosis and Therapy Market Size, 2017-2028
6.7.3 Israel Molecular Diagnosis and Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Molecular Diagnosis and Therapy Market Size, 2017-2028
6.7.5 UAE Molecular Diagnosis and Therapy Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Molecular Diagnosis and Therapy Major Product Offerings
7.1.4 Abbott Laboratories Molecular Diagnosis and Therapy Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Agilent Technologies
7.2.1 Agilent Technologies Corporate Summary
7.2.2 Agilent Technologies Business Overview
7.2.3 Agilent Technologies Molecular Diagnosis and Therapy Major Product Offerings
7.2.4 Agilent Technologies Molecular Diagnosis and Therapy Revenue in Global Market (2017-2022)
7.2.5 Agilent Technologies Key News
7.3 Becton, Dickinson and Company
7.3.1 Becton, Dickinson and Company Corporate Summary
7.3.2 Becton, Dickinson and Company Business Overview
7.3.3 Becton, Dickinson and Company Molecular Diagnosis and Therapy Major Product Offerings
7.3.4 Becton, Dickinson and Company Molecular Diagnosis and Therapy Revenue in Global Market (2017-2022)
7.3.5 Becton, Dickinson and Company Key News
7.4 Biom?rieux Sa
7.4.1 Biom?rieux Sa Corporate Summary
7.4.2 Biom?rieux Sa Business Overview
7.4.3 Biom?rieux Sa Molecular Diagnosis and Therapy Major Product Offerings
7.4.4 Biom?rieux Sa Molecular Diagnosis and Therapy Revenue in Global Market (2017-2022)
7.4.5 Biom?rieux Sa Key News
7.5 Danaher Corporation
7.5.1 Danaher Corporation Corporate Summary
7.5.2 Danaher Corporation Business Overview
7.5.3 Danaher Corporation Molecular Diagnosis and Therapy Major Product Offerings
7.5.4 Danaher Corporation Molecular Diagnosis and Therapy Revenue in Global Market (2017-2022)
7.5.5 Danaher Corporation Key News
7.6 Diasorin
7.6.1 Diasorin Corporate Summary
7.6.2 Diasorin Business Overview
7.6.3 Diasorin Molecular Diagnosis and Therapy Major Product Offerings
7.6.4 Diasorin Molecular Diagnosis and Therapy Revenue in Global Market (2017-2022)
7.6.5 Diasorin Key News
7.7 Grifols
7.7.1 Grifols Corporate Summary
7.7.2 Grifols Business Overview
7.7.3 Grifols Molecular Diagnosis and Therapy Major Product Offerings
7.7.4 Grifols Molecular Diagnosis and Therapy Revenue in Global Market (2017-2022)
7.7.5 Grifols Key News
7.8 Hologic
7.8.1 Hologic Corporate Summary
7.8.2 Hologic Business Overview
7.8.3 Hologic Molecular Diagnosis and Therapy Major Product Offerings
7.8.4 Hologic Molecular Diagnosis and Therapy Revenue in Global Market (2017-2022)
7.8.5 Hologic Key News
7.9 Illumina
7.9.1 Illumina Corporate Summary
7.9.2 Illumina Business Overview
7.9.3 Illumina Molecular Diagnosis and Therapy Major Product Offerings
7.9.4 Illumina Molecular Diagnosis and Therapy Revenue in Global Market (2017-2022)
7.9.5 Illumina Key News
7.10 Qiagen
7.10.1 Qiagen Corporate Summary
7.10.2 Qiagen Business Overview
7.10.3 Qiagen Molecular Diagnosis and Therapy Major Product Offerings
7.10.4 Qiagen Molecular Diagnosis and Therapy Revenue in Global Market (2017-2022)
7.10.5 Qiagen Key News
7.11 Roche Diagnostics
7.11.1 Roche Diagnostics Corporate Summary
7.11.2 Roche Diagnostics Business Overview
7.11.3 Roche Diagnostics Molecular Diagnosis and Therapy Major Product Offerings
7.11.4 Roche Diagnostics Molecular Diagnosis and Therapy Revenue in Global Market (2017-2022)
7.11.5 Roche Diagnostics Key News
7.12 Siemens AG
7.12.1 Siemens AG Corporate Summary
7.12.2 Siemens AG Business Overview
7.12.3 Siemens AG Molecular Diagnosis and Therapy Major Product Offerings
7.12.4 Siemens AG Molecular Diagnosis and Therapy Revenue in Global Market (2017-2022)
7.12.5 Siemens AG Key News
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Corporate Summary
7.13.2 Thermo Fisher Scientific Business Overview
7.13.3 Thermo Fisher Scientific Molecular Diagnosis and Therapy Major Product Offerings
7.13.4 Thermo Fisher Scientific Molecular Diagnosis and Therapy Revenue in Global Market (2017-2022)
7.13.5 Thermo Fisher Scientific Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Molecular Diagnosis and Therapy Market Opportunities & Trends in Global Market
Table 2. Molecular Diagnosis and Therapy Market Drivers in Global Market
Table 3. Molecular Diagnosis and Therapy Market Restraints in Global Market
Table 4. Key Players of Molecular Diagnosis and Therapy in Global Market
Table 5. Top Molecular Diagnosis and Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Molecular Diagnosis and Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Molecular Diagnosis and Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Molecular Diagnosis and Therapy Product Type
Table 9. List of Global Tier 1 Molecular Diagnosis and Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Diagnosis and Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Molecular Diagnosis and Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Molecular Diagnosis and Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Molecular Diagnosis and Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Molecular Diagnosis and Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Molecular Diagnosis and Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Molecular Diagnosis and Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Molecular Diagnosis and Therapy Product Offerings
Table 32. Abbott Laboratories Molecular Diagnosis and Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Agilent Technologies Corporate Summary
Table 34. Agilent Technologies Molecular Diagnosis and Therapy Product Offerings
Table 35. Agilent Technologies Molecular Diagnosis and Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Becton, Dickinson and Company Corporate Summary
Table 37. Becton, Dickinson and Company Molecular Diagnosis and Therapy Product Offerings
Table 38. Becton, Dickinson and Company Molecular Diagnosis and Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Biom?rieux Sa Corporate Summary
Table 40. Biom?rieux Sa Molecular Diagnosis and Therapy Product Offerings
Table 41. Biom?rieux Sa Molecular Diagnosis and Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Danaher Corporation Corporate Summary
Table 43. Danaher Corporation Molecular Diagnosis and Therapy Product Offerings
Table 44. Danaher Corporation Molecular Diagnosis and Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Diasorin Corporate Summary
Table 46. Diasorin Molecular Diagnosis and Therapy Product Offerings
Table 47. Diasorin Molecular Diagnosis and Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Grifols Corporate Summary
Table 49. Grifols Molecular Diagnosis and Therapy Product Offerings
Table 50. Grifols Molecular Diagnosis and Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Hologic Corporate Summary
Table 52. Hologic Molecular Diagnosis and Therapy Product Offerings
Table 53. Hologic Molecular Diagnosis and Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Illumina Corporate Summary
Table 55. Illumina Molecular Diagnosis and Therapy Product Offerings
Table 56. Illumina Molecular Diagnosis and Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Qiagen Corporate Summary
Table 58. Qiagen Molecular Diagnosis and Therapy Product Offerings
Table 59. Qiagen Molecular Diagnosis and Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Roche Diagnostics Corporate Summary
Table 61. Roche Diagnostics Molecular Diagnosis and Therapy Product Offerings
Table 62. Roche Diagnostics Molecular Diagnosis and Therapy Revenue (US$, Mn), (2017-2022)
Table 63. Siemens AG Corporate Summary
Table 64. Siemens AG Molecular Diagnosis and Therapy Product Offerings
Table 65. Siemens AG Molecular Diagnosis and Therapy Revenue (US$, Mn), (2017-2022)
Table 66. Thermo Fisher Scientific Corporate Summary
Table 67. Thermo Fisher Scientific Molecular Diagnosis and Therapy Product Offerings
Table 68. Thermo Fisher Scientific Molecular Diagnosis and Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Molecular Diagnosis and Therapy Segment by Type in 2021
Figure 2. Molecular Diagnosis and Therapy Segment by Application in 2021
Figure 3. Global Molecular Diagnosis and Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Molecular Diagnosis and Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Molecular Diagnosis and Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Diagnosis and Therapy Revenue in 2021
Figure 8. By Type - Global Molecular Diagnosis and Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Molecular Diagnosis and Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Molecular Diagnosis and Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Molecular Diagnosis and Therapy Revenue Market Share, 2017-2028
Figure 12. US Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Molecular Diagnosis and Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Molecular Diagnosis and Therapy Revenue Market Share, 2017-2028
Figure 24. China Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Molecular Diagnosis and Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Molecular Diagnosis and Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Agilent Technologies Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Becton, Dickinson and Company Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biom?rieux Sa Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Danaher Corporation Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Diasorin Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Grifols Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Hologic Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Illumina Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Qiagen Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Roche Diagnostics Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Siemens AG Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Thermo Fisher Scientific Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
